# Study of Progesterone in Treatment of Vasomotor Symptoms

> **NCT03202186** · PHASE3 · TERMINATED · sponsor: **BHR Pharma, LLC** · enrollment: 55 (actual)

## Conditions studied

- Menopause Related Conditions

## Interventions

- **DRUG:** Progesterone oral capsule
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03202186
- **Lead sponsor:** BHR Pharma, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-01
- **Primary completion:** 2018-12-06
- **Final completion:** 2018-12-06
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Inability to recruit subjects
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03202186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03202186, "Study of Progesterone in Treatment of Vasomotor Symptoms". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03202186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*